Pain in the neurodegenerating brain: insights into pharmacotherapy for Alzheimer disease and Parkinson disease
- PMID: 33239526
- PMCID: PMC7977618
- DOI: 10.1097/j.pain.0000000000002111
Pain in the neurodegenerating brain: insights into pharmacotherapy for Alzheimer disease and Parkinson disease
Conflict of interest statement
C. Ballard reports grants and personal fees from Acadia pharmaceutical company, grants and personal fees from Lundbeck, personal fees from Roche, personal fees from Otsuka, personal fees from Biogen, personal fees from Eli Lilly, personal fees from Novo Nordisk, personal fees from AARP, grants and personal fees from Synexus, and personal fees from Exciva, all outside the submitted work. The remaining authors have no conflicts of interest to declare.
Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.
Figures
Comment in
-
On the diagnosis of pain in Parkinson disease: a mechanism-based approach.Pain. 2022 Mar 1;163(3):e495-e496. doi: 10.1097/j.pain.0000000000002446. Pain. 2022. PMID: 35148288 No abstract available.
-
Response to Mylius et al.Pain. 2022 Mar 1;163(3):e496-e497. doi: 10.1097/j.pain.0000000000002445. Pain. 2022. PMID: 35148289 No abstract available.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical